Jeffrey Wolf, MD, on Emerging T-Cell Engagers and Their Impact in Multiple Myeloma
The interview features comments on the emergence of T-cell engagers for therapy in patients with multiple myeloma made during the 2020 ASH Meeting & Exposition.
Jeffrey Wolf, MD, on Next-Generation CAR T Cell Therapy and the Future of Multiple Myeloma Treatments
Wolf discusses the potential for emerging next-generation CAR T-cell treatment and the future of treating patients with multiple myeloma.
2 Clarke Drive Cranbury, NJ 08512